More on PGNX
Data
Financials
News
Click line-items for a historical chart and %
| Collaboration revenue | |
| Royalty income | 3.32M |
| Research grants | |
| Other revenues | 8K |
| Total revenues | |
| Research and development | |
| License fees - research and development | |
| General and administrative | 7.22M |
| Royalty expense | |
| Depreciation and amortization | |
| Total expenses | |
| Operating income (loss) | 36.2M |
| Interest income | 79K |
| Total other income | 79K |
| Net income (loss) | 36.3M |
| Net income (loss) per share - basic | |
| Weighted-average shares - basic | |
| Net income (loss) per share - diluted | 0.52 |
| Weighted-average shares - diluted | |
Entities mentioned with PGNX
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Needham & Company | View Related Stories »
- Jefferies & Co | View Related Stories »
- PDUFA | View Related Stories »
- 13G | View Related Stories »
- Pre Market Movers | View Related Stories »
- Show More...
